Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.
Chen
Z J
ZJ
Department of Microbiology, New York Medical College, Valhalla 10595.
Yang
H
H
Liu
C C
CC
Mittelman
A
A
Ferrone
S
S
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000096:biosynthesis / Q000276:immunology / Q000627:therapeutic use*; D000951:Antigens, Neoplasm / Q000276:immunology*; D006801:Humans; D007114:Immunization; D007167:Immunotherapy; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D008546:Melanoma, Experimental / Q000628:therapy; D058950:Melanoma-Specific Antigens; D051379:Mice; D008807:Mice, Inbred BALB C / Q000276:immunology; D009363:Neoplasm Proteins / Q000276:immunology*; D009368:Neoplasm Transplantation; D011817:Rabbits; D016019:Survival Analysis; D014183:Transplantation, Heterologous
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins